HOPE

Analyst Note: HOPE (Hope Bancorp, Inc.)

Date: 2026-06-13 Current Price: $12.84

1. Structural Readiness

State: Context-Only Conservative Entry: — Breakout Level: — Extension: — ATR Current: 2.3% (Sub-threshold)

Structural Assessment:

• Volatility Context: The current ATR of 2.3% falls into the "sub-threshold" bucket (<2.5%). In the StoryStocks canon, this indicates weak volatility and a lack of the momentum required to signal a high-probability structural breakout. This is a negative structural signal for immediate setup readiness, suggesting the market is currently in a consolidation or low-conviction phase rather than a trend initiation.

2. Thesis Layer

Thesis Classification: Tactical / Setup-Led Secular Exposure: None Named

At this date, HOPE is classified as a Tactical, setup-led name. There is no named macro or secular thesis driving the immediate investment case. The investment rationale must be derived strictly from the quality of the business fundamentals and the eventual formation of a technical setup, rather than a pre-existing macro narrative. Investors should judge this name on its operational execution and the clarity of its recent strategic moves (specifically the MANUBANK transaction) rather than expecting a broad sector tailwind.

3. Business Overview

Company: Hope Bancorp, Inc. (Parent of Bank of Hope) Industry: Regional Banking / Financial Services Business Model: A diversified regional bank serving multicultural communities, with a specific focus on Asian multinational businesses, commercial lending, and consumer banking.

Operational Snapshot (as of Q1 2026 / June 2026):

• Scale & Footprint: As of March 31, 2026, the company reported total assets of $18.66 billion. The bank operates 45 full-service branches in the continental U.S. (California, New York, New Jersey, Washington, Texas, Illinois, Georgia, Alabama) and 28 branches in Hawaii under the Territorial Savings banner.
• Strategic Expansion (MANUBANK): On March 31, 2026, the company announced the acquisition of the Commercial Banking unit of SMBC MANUBANK. Management expects this transaction to close in the second half of 2026, subject to regulatory approvals.
• Asset Impact: The transaction is expected to add approximately $2.5 billion in commercial and industrial (C&I) and commercial real estate (CRE) loans, and $2.7 billion in deposits.
• Deposit Quality: Management noted that only approximately 3% of these new deposits are Certificates of Deposit (CDs), implying a high proportion of low-cost, transactional deposits.
• Strategic Fit: The acquisition is designed to deepen presence in the Greater Los Angeles market and combine SMBC MANUBANK's Japanese banking division with Hope's existing Korean subsidiary to serve Asian multinational businesses.
• Financial Performance (Q1 2026):
• Net Interest Income (NII): Increased 23.1% year-over-year to $124.1 million (vs. $100.8 million in Q1 2025).
• Net Interest Margin (NIM): Expanded 36 basis points to 2.90% (vs. 2.54% in Q1 2025).
• Net Income: Rose to $29.5 million ($0.23 per diluted share), up from $21.1 million ($0.17 per share) in the prior year period.
• Growth Guidance (Management Expectations):
• Loan Growth: Management expects loan growth of over 20% between December 31, 2025, and December 31, 2026, driven by the MANUBANK transaction and organic growth.
• Revenue Growth: Anticipated year-over-year total revenue growth of 15% to 20% for the full year 2026.
• Pre-Provision Net Revenue (PPNR): Projected to grow 25% to 30% excluding notable items.
• Earnings Accretion: Management projects the transaction to be "meaningfully accretive to earnings in 2027" and to improve returns on equity without issuing new shares.

4. Archetype and Conviction Stack

Archetype: Growth Leader / Margin Inflector The company is currently transitioning from a regional operator to a scaled, diversified platform through the MANUBANK acquisition. The archetype is defined by:

• Margin Expansion: The NIM expansion to 2.90% and the low-cost deposit profile of the incoming MANUBANK assets suggest a margin inflector dynamic.
• Scale-Driven Growth: The 20% loan growth guidance and the addition of $5.2 billion in combined assets (loans + deposits) position the firm as a growth leader within its regional peer set.
• Niche Dominance: The unique positioning serving Asian multinational businesses (Japanese/Korean banking integration) creates a differentiated moat.

Conviction Stack Analysis:

• Thesis Strength: Low (Tactical). No macro thesis is active; the case rests entirely on execution.
• Evidence Quality: High. The evidence base is robust, featuring specific Q1 2026 financials, detailed transaction metrics ($2.5B loans, $2.7B deposits), and clear management guidance for 2026-2027.
• Structural Quality: Weak. The current ATR of 2.3% is sub-threshold, and the setup is "context-only." There is no technical structure (coil) to validate the fundamental strength.
• Rerating Potential: Moderate to High. If the MANUBANK transaction closes as expected in H2 2026 and accretion materializes in 2027, the market may re-rate the stock based on the new asset base and improved ROE. However, this is a fundamental rerating, not a technical one.

Valuation Context: The financial spine indicates a forward consensus EPS of $1.07 for FY1 and $1.5225 for FY2. At a current price of $12.84, the stock trades at approximately 12.0x FY1 and 8.4x FY2. This implies the market is pricing in significant growth, but the lack of technical momentum suggests the market is currently waiting for the transaction to close before fully repricing.

5. Invalidations, Strengths, and Gaps

What Would Strengthen the Case:

• Successful Closing of MANUBANK: Confirmation that the transaction closes in H2 2026 without regulatory hurdles.
• Technical Breakout: A move above a defined resistance level with ATR expanding into the 4-6% "sweet spot," confirming the fundamental story with price action.
• Deposit Retention: Evidence that the low-cost deposit base from MANUBANK is retained post-merger.

What Would Invalidate the Case:

• Transaction Failure: Regulatory rejection or failure to close the MANUBANK deal.
• Credit Deterioration: A spike in non-performing loans (NPLs) in the C&I or CRE sectors, particularly in the new portfolio.
• Margin Compression: A reversal of the NIM trend (falling below 2.54%) due to funding cost increases or asset yield compression.

Gaps in Evidence Base:

• Integration Risk: No specific data on the cost of integration or the timeline for synergies to materialize beyond the 2027 earnings accretion claim.
• Regulatory Timeline: While management expects a close in H2 2026, the specific regulatory hurdles and the probability of delay are not quantified in the provided evidence.

PRIVATE ANALYST CALL

Judgment: Hold Confidence: medium Key evidence: Q1 2026 NIM expansion to 2.90% and 23.1% NII growth; Management guidance for >20% loan growth in 2026 driven by MANUBANK; Forward consensus EPS of $1.52 for FY2 implies significant growth trajectory. Sizing hint: Position size should be minimal or zero until a technical structure forms; fundamental conviction is high but timing is uncertain. Expected path: Management expects the MANUBANK transaction to close in H2 2026, followed by earnings accretion in 2027; price likely to remain range-bound or drift lower until the deal closes or a technical breakout occurs. Expected horizon: 6 to 12 months (aligned with transaction closing and 2027 earnings realization).